BiotechTube
Presymptom Health

Presymptom Health

Cambridge, United Kingdom· Est.
presymptom.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.5M

Overview

Presymptom Health was a private, pre-revenue diagnostics startup operating from the Cambridge biotech cluster with the goal of detecting diseases before symptoms appear. The company has ceased operations and entered a solvent liquidation process (MVL) as of April 2026, indicating a decision by its shareholders to wind down the company while it is still able to pay its debts. All inquiries are now directed to the appointed liquidators from Moorfields Advisory. The specific reasons for the wind-down, the nature of its technology, and the outcomes of its research programs remain undisclosed.

Diagnostics

Technology Platform

Focus on pre-symptomatic disease detection; specific platform details undisclosed.

Funding History

1
Total raised:$1.5M
Seed$1.5M

Opportunities

The market for early, pre-symptomatic diagnostics is large and growing, driven by the shift towards preventive healthcare.
Success in this field offers the potential for transformative patient outcomes and significant economic value in multiple disease areas.

Risk Factors

Extreme technical and clinical validation risks in achieving necessary sensitivity/specificity.
High capital requirements and long development timelines create severe funding risk.
Difficult commercialization pathway due to regulatory and reimbursement hurdles.

Competitive Landscape

The pre-symptomatic diagnostics space is highly competitive, featuring well-funded public companies, large medtech players, and numerous startups. Competition is based on technological performance, clinical evidence, intellectual property, and securing partnerships with healthcare systems.

More companies in Diagnostics & Precision Medicine →More companies in United Kingdom →